Background: As both intravoxel incoherent motion (IVIM) modeling and dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) provide perfusion parameters, IVIM-derived perfusion parameters might be expected to correlate with the kinetic features from DCE-MRI. Purpose: To investigate the association between IVIM parameters and prognostic factors and to evaluate the correlation between IVIM parameters and kinetic features in invasive breast cancer patients using computer-aided diagnosis (CAD). Study Type: Retrospective. Population: Eighty-five patients (invasive cancers; mean size, 1.8 cm; range, 0.8-4.8 cm) who underwent diffusion-weighted imaging with 12 b-values (0-1000 s/mm 2 ). Field Strength/Sequence: 3.0T MRI axial, IVIM-DWI epi-sequence, and DCE-MRI. Assessment: Two radiologists measured the apparent diffusion coefficient (ADC), diffusion coefficient, pseudodiffusion coefficient, and perfusion fraction (f) using IVIM modeling. Kinetic features such as peak enhancement and early and delayed enhancement profiles were acquired using CAD. Statistical Tests: The correlation between the IVIM parameters and kinetic features and the association between the IVIM parameters and prognostic factors were investigated using Mann-Whitney test and Spearman correlation test. Results: There were no significant associations between IVIM parameters and prognostic factors. When IVIM parameters were correlated with kinetic features by CAD, both the ADC and f values showed correlations with delayed enhancement profiles. The ADC values were lower in tumors with lower persistent components (P = 0.013) and higher washout components (P = 0.045) and showed a positive correlation with persistent proportion (Spearman's rho (r) = 0.222, P = 0.041). The f value was higher in tumors with higher persistent components (P = 0.021) and showed a positive correlation with persistent proportion (r = 0.227, P = 0.029). Data Conclusion: This analysis revealed that IVIM-derived ADC and f values showed correlations with kinetic features at the delayed phase as assessed by CAD. These results indicate the potential of IVIM imaging biomarkers to provide information on the biological and kinetic properties of breast cancers without a contrast agent. Level of Evidence: 4 Technical Efficacy: Stage 2
prognostic markers is required. Diffusion-weighted imaging (DWI) plays a significant role in revealing tumor cellularity, as increased tumor cellularity leads to decreased apparent diffusion coefficient (ADC) values. 3 However, breast cancers possess both high cellularity and vascularity; DWI signal decay can be influenced by both. 2 Intravoxel incoherent motion (IVIM) modeling from multi-b-value DWI is an interesting imaging technique that provides separate measurements of diffusion and perfusion. Through IVIM, not only can pure diffusion (D) be separated, but perfusion parameters such as pseudodiffusion (Dp) and the microvascular volume fraction (f ) can also be acquired without the use of a contrast agent. 4 When investigating the application of IVIM modeling in breast lesions, most studies have focused on the additional role of IVIM parameters to differentiate between benign and malignant breast lesions. 2, [5] [6] [7] [8] [9] Recently, some studies have investigated the association between the IVIM parameters and the prognostic factors of breast cancers. 6, 10, 11 However, there has been little agreement between the results. While some investigators reported a correlation between Dp or D values and hormonal expression, 6, 10 another reported a correlation between the D value and Ki-67 expression. 11 Thus, further studies are needed to determine the association of IVIM parameters with prognostic factors in breast cancers. As both IVIM modeling and dynamic contrastenhanced magnetic resonance imaging (DCE-MRI) provide these perfusion parameters, IVIM-derived perfusion parameters were expected to correlate with the kinetic features from DCE-MRI. Several previous studies have attempted to reveal the correlation between the IVIM-derived f value and the initial upslope enhancement of DCE-MRI 2, 5, 12 because the initial enhancement slope primarily depends on the tissue perfusion flow. 13 In breast cancers, Sigmund et al 2 found a modest correlation; however, Bokacheva et al 5 did not. This correlation was also reported in hepatocellular carcinomas. 12 Thus, we hypothesized that the f value from IVIM modeling may correlate with quantitative kinetic features from a DCE-MRI using computer-aided diagnosis (CAD). Furthermore, several CAD-assessed kinetic features, such as a higher washout component and a higher peak enhancement of the tumor at preoperative MRI, are known as poor survival indicators in breast cancer patients. [14] [15] [16] Demonstrating the relationship between CAD-assessed kinetic features and IVIM parameters could be helpful in characterizing complex cancerous tissue and in predicting prognosis in breast cancer patients. The purpose of this study was to investigate the association between IVIM parameters and prognostic factors and to evaluate the correlation between IVIM parameters and kinetic features in invasive breast cancer patients using CAD.
Materials and Methods

Patient and Tumor Characteristics
The Institutional Review Board approved this retrospective study and waived the requirement for informed patient consent (IRB number AN16327-001). Between July 2016 and March 2017, 121 consecutive women with newly diagnosed invasive breast cancers, confirmed by imaging-guided core needle biopsy, underwent preoperative DCE-MRI and DWI using 12 b-values. We excluded women who 1) received neoadjuvant chemotherapy before surgery (n = 19); 2) showed poor lesion visibility on IVIM parameter maps for analysis (n = 7); 3) had inadequate CAD-generated images (n = 7); and 4) did not undergo curative surgery at our institution (n = 3). Ultimately, 85 women (mean age: 54 years; range: 35-81 years) with 85 invasive breast tumors (mean, 1.8 cm; range, 0.8-4.8 cm) were enrolled in this study. The median interval between preoperative DCE-MRI and surgery was 7 days (range, 2-29 days).
MRI
All breast MRI examinations were performed using a Magnetom Prisma 3T scanner (Siemens Healthcare, Erlangen, Germany) with a dedicated, phased-array 16-channel breast coil in the axial orientation. The median interval between biopsy and the MRI examination was 9 days (range, 6-21 days). Patients were placed in a prone position. MRI sequences included a T 2 -weighted fast spin-echo sequence, a T 1 -weighted nonfat-suppressed fast spin-echo sequence, a prototype IVIM-DWI episequence, and one pre-and six postcontrast dynamic series immediately after and at 60, 120, 180, 240, and 300 seconds after an intravenous injection of a contrast agent (Dotarem, Guerbet, Villepinte, France). The detailed imaging parameters of the DCE-MRI and IVIM-DWI are described in Table 1 .
IVIM Modeling of DWI
Postprocessing of the DWI data was conducted using prototype software (MR Body Diffusion Tool Box 1.2.0) provided by the manufacturer (Siemens Healthcare) to acquire the IVIM parameters ADC, D, Dp, and f. A voxel-by-voxel fitting of the IVIM data was performed using the following equation of Le Bihan et al 4 :
where S is the mean signal intensity according to the b-value, S 0 is the DWI acquired without diffusion-weighting (b = 0 s/mm 2 ), f is the microvascular volume fraction, D is the diffusion coefficient and represents pure molecular diffusivity, and Dp is the pseudodiffusion coefficient and represents perfusion-related incoherent microcirculation. The fitting is initialized by log-linear estimation of the perfusion component using b values <200 s/mm 2 and the true diffusion component using b values ≥200 s/mm 2 . Then simultaneous, nonlinear optimization of S 0 , D, Dp, and f was performed using the Nelder-Mead algorithm.
Image Analysis
Identification of cancers and manual drawing of the region of interest (ROI) on the software were independently performed by two breast radiologists (K.R.C. and S.E.S. with 17 and 7 years of experience, respectively) blinded to the clinical-pathologic features. A single representative ROI was traced along the margin of the cancers on the ADC maps, on the section including the largest cross-sectional area of the tumor ( Figs. 1 and 2 ). Cystic areas were avoided by using T 2 -weighted and contrast-enhanced T 1 -weighted sequences as references. In case of multiple tumors in a breast, only the largest lesion was selected. Then the same ROI was copied and pasted into the IVIM parametric maps. The software reported the ROI-based statistics of the IVIM parametric maps. All DCE-MRI images were transferred to a CAD system (CADstream, v. 6.0, Confirma, Kirkland, WA). One radiologist (S.E.S. with 7 years of experience in breast imaging) selected the tumor above a set enhancement threshold of 50% on a CAD system at the same slice of the IVIM parametric maps. The kinetic parameters of peak enhancement, angio-volume (total volume of the enhancing lesion), and early (proportions of medium and rapid enhancing components), and delayed enhancement profiles (proportions of persistent, plateau, and washout component) were calculated for each lesion.
Histological Evaluation
Breast-conserving surgery (n = 60) or mastectomy (n = 25) was performed for all patients. Patient records such as tumor size, histologic type and grade, presence of ductal carcinoma in situ (DCIS), nodal status, lymphovascular invasion, Ki-67 expression, and estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor type 2 (HER2) statuses were reviewed. ER or PR positivity was determined by stained nuclei in >1% of cancer cells in 10 high-power fields. The HER2 staining intensity was scored as 0, 1+, 2+, or 3+. 17 Tumors with scores of 3 + were classified as HER2-positive, and those with scores of 0 or 1 + as HER2-negative. Tumors with 2 + scores were further assessed with fluorescence in situ hybridization to determine the HER2 status. The molecular subtype of the tumor was categorized into luminal type (ER-or PR-positive, HER2-negative), HER2-enriched type (HER2-positive), and triple-negative type (ER-and PR-negative, HER2-negative). 18 A cutoff value of 14% was used to divide Ki-67 expression status into low-and high-expression groups. 19 
Statistical Analysis
All cases were assigned to one of two groups according to dichotomized clinical-pathologic features and CAD-generated kinetic features, and the two groups were compared using Mann-Whitney Utests for nonnormally distributed samples. For comparison of IVIM parameters according to three breast cancer subtypes, the KruskalWallis test were used. The Spearman rank correlation test was used to acquire the correlation coefficient rho (r) between IVIM parameters and Ki-67 expression or CAD-assessed kinetic features. Intraclass agreement of IVIM parameters was computed from two measurements by reader 1; interclass agreement was computed from the first measurements of reader 1 and reader 2. An interclass correlation coefficient >0.75 indicated good agreement. 20 All data analyses were performed using SPSS Statistics for Windows, v. 20 (IBM, Armonk, NY); P < 0.05 was considered significant.
Results
Clinical-Pathologic Features
The mean size of the 85 invasive cancers was 1.8 cm (range: 0.8-4.8 cm); 51 patients had a pT1 (≤2 cm) and 24 had a pT2 (>2 cm Table 2 .
Associations Between IVIM Parameters and Prognostic Factors
The median Dp value of cancers without lymphovascular invasion (16.00 ± 15.10 × 10 −3 mm 2 /s) was higher than that of cancers with lymphovascular invasion (14.00 ± 3.73 × 10 −3 mm 2 /s) with borderline significance (P = 0.071) (Table 2 ). However, our results showed that there were no statistically significant prognostic factors associated with IVIM parameters.
Associations Between CAD-Assessed Kinetic Features and Prognostic Factors
The median angio-volume showed differences according to histologic grade, tumor size, ER and PR positivity, Ki-67 index, and molecular subtype with statistical significance (all P < 0.05) ( Table 3 ). The median peak enhancement showed differences according to histologic grade, tumor size, Ki-67 index, and molecular subtype (all P < 0.05). The median early rapid enhancement proportion was significantly higher in tumors with high Ki-67 index than in tumors with low Ki-67 index (P = 0.042); however, the median delayed persistent proportion or the median delayed washout proportion 17.00 ± 8.50
ADC, apparent diffusion coefficient; D, diffusion coefficient; Dp, pseudodiffusion coefficient; f, perfusion fraction; DCIS, ductal carcinoma in situ; ER, estrogen receptor; PR, progesterone receptor; HER2, human epidermal growth factor receptor type 2. showed no statistically significant differences according to prognostic factors (all P > 0.05). (Table 4) (Fig. 3) . In the Spearman rank correlation test, the ADC value showed slight positive correlations with the CAD-assessed angio-volume (r = 0.227; P = 0.037) and CAD-assessed delayed persistent proportion (r = 0.222; P = 0.041), and showed a slight negative correlation with borderline significance (r = -0.195; P = 0.073) with the CAD-assessed washout proportion ( Table 5) .
Correlations Between IVIM Parameters and CADAssessed Kinetic Features
The median D value was also lower in tumors with a small angio-volume than in tumors with a large angio-volume (0.79 vs. 0.84 × 10 −3 mm 2 /s, P = 0.051) with borderline significance; however, there was no statistically significant correlation found in the correlation test (r = 0.167; P = 0.127).
The median f value was higher in tumors with higher persistent proportions than in tumors with lower persistent proportions (16.50% vs. 15.00%; P = 0.021) ( Table 4 ) (Fig. 4) . In the correlation test, f value showed a positive correlation with the CAD-assessed delayed persistent proportion (r = 0.227; P = 0.029) (Table 5 ). However, f value showed no correlations with the CAD-assessed early rapid enhancement proportion (r = -0.014; P = 0.897) or early medium enhancement proportion (r = 0.014; P = 0.897). 
Interclass Agreement of IVIM Parameters
Discussion
This study revealed a significant association between IVIMderived ADC values and CAD-assessed kinetic features from DCE-MRI. The ADC value is a quantifiable value that provides a measurement of tissue cellularity, which is influenced not only by water diffusion but also by perfusion. 4, [21] [22] [23] [24] The perfusion effect may result in overestimation of the ADC value owing to an increased microvessel count for tumor angiogenesis. 2, 25 Throughout the IVIM, the D value, which reports more precise cellularity and provides increased specificity in diagnosing breast cancer, can be acquired by avoiding microcirculation contributions. 2, [4] [5] [6] [7] [8] 25 In our study the perfusion effect assessed by CAD actually contributes to the ADC value, which was significantly lower in tumors with smaller angio-volumes, lower persistent components, and higher washout components. In correlation tests, ADC values showed a positive correlation with delayed persistent proportion. In contrast, D value was also lower, with borderline significance, in tumors with smaller angio-volume, but it showed no significant correlations with any kinetic features. These results suppose that perfusion effects such as enhancement kinetics at the delayed phase affect ADC value rather than D value. With respect to the prognostic value of ADC, a lower ADC value was proven to be associated with worse distant metastasis-free survival in breast cancer patients. 26 Several previous researchers insisted that a lower ADC value could be a potential noninvasive marker of breast cancer aggressiveness. [27] [28] [29] Regarding the prognostic value of CADassessed kinetics, a higher washout component 14 and a higher peak enhancement [14] [15] [16] at preoperative MRI were associated with poorer survival outcomes in breast cancer patients. In our study, the ADC value was significantly lower in tumors with a higher washout component on CAD but was not lower in tumors with a higher peak enhancement. Considering that both the lower ADC values and the higher washout components were known to be associated with a poor prognosis, 14, [26] [27] [28] [29] this relationship of lower ADC values in tumors with a higher washout component might be used to predict survival outcomes in breast cancer patients if the specific mechanism is clarified. The f value, known to reflect angiogenic neovascularity, 2, 25 showed no correlation with early enhancement profiles, but did show a positive correlation with delayed enhancement profiles. Tissue enhancement kinetics are the sum of tissue perfusion and the interstitial accumulation of the contrast agent due to simultaneous capillary leakage. 13 While the enhancement slope of DCE-MRI primarily depends on the tissue perfusion flow, the declining slope after peak enhancement depends on interstitial accumulation. 13 Thus, previous investigations attempted to reveal associations between the f value and the initial upslope enhancement. Sigmund et al 2 reported a modest correlation; however, Bokacheva et al 5 reported no correlation. Although it is still unclear how closely the f value relates to delayed persistent proportions in our study, it could be postulated by the effect of "late enhancement," which corresponds to a progressive interstitial accumulation and combines with the rapid initial slope of enhancement. 13 Therefore, the f value seems to be influenced not only by the quantity of neovascularity, but also by the incoherent flow in small vessels. 25 As the median f values were reported to be higher in breast cancers (9.1-11.9%) than in benign lesions (5.0-5.3%) or normal breast tissue (1.5-8.3%), [5] [6] [7] 11, 18 it was suggested that the most aggressive breast cancers could show the highest f values. 2 However, based on our results, we propose that a higher f value might not be associated with increased aggressiveness because f seems to be influenced by temporal enhancement kinetics. Our results showed that IVIM parameters displayed no significant association with prognostic factors of invasive breast cancers. Previously, two studies reported that ER expression showed significant correlations with IVIM-derived D values 6 and Dp values. 10 However, there was no significant correlation between the ER expression and D or Dp values in our study. Another study reported a correlation between the D value and Ki-67 expression 11 ; however, in that study DWI was acquired after administration of a contrast agent, which could affect the IVIM parameters. 30 In our study there was no association between the D value and Ki-67 expression. Thus, further larger studies are needed to investigate the association of IVIM parameters with prognostic factors in breast cancers. This study has several limitations. First, the measurements of the IVIM parameters used the ROI on one representative slice; they did not encompass the entire tumor volume. Although our measurements were similar to those of most studies investigating IVIM parameters, 4, 5, 7, 8, 11 some recent studies 6,10 have provided histogram analysis, which could show less fitting artifacts from the parametric map. Second, the range of f value (9.82-48.56%) was relatively high as compared to those (0-46.74%) from the literature. [5] [6] [7] [8] [9] [10] [11] 31 Those high values likely reflect residual tissue diffusion, which can be attributed to the heterogeneity of the tumors. However, according to a recent study using histogram analysis, 6 the maximum f value of invasive breast cancers was reported as 46.74%, which was similar to our study result and we used the median value rather than the mean value in our statistical analysis to avoid average trap. Third, as the DWI acquisition resolution was low, several subcentimeter lesions were measured using small acquisition pixels. However, we made an effort to exclude seven cases that showed poor lesion visibility on IVIM parameter maps for analysis in our patient selection. Fourth, 19 patients with breast cancer who underwent neoadjuvant chemotherapy before surgery were excluded. This may have introduced selection bias. Lastly, the sample size was small. Larger, prospective studies may be needed for a further investigation to validate the correlation of IVIM parameters and CAD-assessed kinetic features.
In conclusion, we found that the perfusion effect contributed to the ADC value, which was lower in tumors with a smaller angio-volume, lower persistent component, and higher washout component. In addition, we also revealed that the IVIM-derived f value showed a positive correlation with the delayed persistent proportion. From our results, we speculate that aggressive invasive breast cancer might show a lower ADC value and a higher washout component, but might not show a higher f value. If our results are confirmed with prospective studies, imaging biomarkers from IVIM modeling may help determine the biological and kinetic properties of invasive breast cancers without a contrast agent.
